ATTOBODY Trademark
Trademark Overview
On Tuesday, March 26, 2024, a trademark application was filed for ATTOBODY with the United States Patent and Trademark Office. The USPTO has given the ATTOBODY trademark a serial number of 98468392. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Wednesday, January 8, 2025. This trademark is owned by Attovia Therapeutics, Inc.. The ATTOBODY trademark is filed in the Pharmaceutical Products category with the following description:
biotherapeutics, namely pharmaceutical preparations for the treatment of cardiovascular diseases, allergy, immune and inflammatory diseases, metabolic diseases, pain, respiratory diseases, gastrointestinal diseases, cancer, diseases of the central nervous system, neurological and psychiatric disorders, neurodegenerative diseases, infectious diseases; biotherapeutics, namely pharmaceutical preparations for the treatment of livestock diseases, namely, allergy, immune and inflammatory diseases, metabolic diseases, pain, respiratory diseases, gastrointestinal diseases, cancer, diseases of the central nervous system, neurological and psychiatric disorders, neurodegenerative diseases, and infectious diseases
General Information
| Serial Number | 98468392 |
| Word Mark | ATTOBODY |
| Filing Date | Tuesday, March 26, 2024 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Wednesday, January 8, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | biotherapeutics, namely pharmaceutical preparations for the treatment of cardiovascular diseases, allergy, immune and inflammatory diseases, metabolic diseases, pain, respiratory diseases, gastrointestinal diseases, cancer, diseases of the central nervous system, neurological and psychiatric disorders, neurodegenerative diseases, infectious diseases; biotherapeutics, namely pharmaceutical preparations for the treatment of livestock diseases, namely, allergy, immune and inflammatory diseases, metabolic diseases, pain, respiratory diseases, gastrointestinal diseases, cancer, diseases of the central nervous system, neurological and psychiatric disorders, neurodegenerative diseases, and infectious diseases |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, March 26, 2024 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Attovia Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Fremont, CA 94538 |
Trademark Events
| Event Date | Event Description |
| Tuesday, March 26, 2024 | NEW APPLICATION ENTERED |
| Tuesday, April 2, 2024 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, October 4, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, October 4, 2024 | NON-FINAL ACTION WRITTEN |
| Friday, October 4, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, October 4, 2024 | ASSIGNED TO EXAMINER |
| Monday, January 6, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, January 6, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, January 6, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, January 8, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
